SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 1.48 |
Enterprise Value ($M) | 18.20 |
Book Value ($M) | 41.02 |
Book Value / Share | 4.95 |
Price / Book | 0.04 |
NCAV ($M) | -19.85 |
NCAV / Share | -2.39 |
Price / NCAV | -0.07 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.01 |
Return on Assets (ROA) | -0.59 |
Return on Equity (ROE) | -36.74 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.05 |
Current Ratio | 0.06 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 1.05 |
Assets | 61.92 |
Liabilities | 20.90 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Bruhlmann Christian | 4.20 | ||
13D/A | Schiess Ralph | 4.63 | ||
13G/A | Zurcher Kantonalbank (Zurich Cantonalbank) | 2.50 | -63.09 | |
13G | Scablis AG | 7.00 | ||
13G | New Horizon Health Ltd | 6.91 | ||
13D | Altos Venture AG | 32.50 | 144.33 | |
13G/A | Hernandez Joseph | 0.00 | -100.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
183,059 | 748,306 | 24.46 | |
1,064,220 | 3,252,582 | 32.72 | |
314,450 | 1,916,745 | 16.41 | |
464,677 | 1,440,735 | 32.25 | |
(click for more detail) |
Similar Companies | |
---|---|
OCGN – Ocugen, Inc. | OCX – OncoCyte Corporation |
OKYO – OKYO Pharma Limited | ONCY – Oncolytics Biotech Inc. |
ONVO – Organovo Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io